Common questions about Diclac (FAQ)
Q: What is the difference between Diclac and the drug sold under the brand name Voltaren?
Diclac contains the active ingredient diclofenac. Voltaren is simply another widely recognized brand name for the exact same substance, a non-steroidal anti-inflammatory drug (NSAID). Both brands contain the same primary active ingredient, though they may offer different formulations of the drug.
Q: Why is Diclac usually only available with a prescription?
Regulatory authorities reclassified oral diclofenac as prescription-only in many regions due to a small but increased risk of serious cardiovascular problems, like heart attack or stroke. Regulatory guidance indicates that a healthcare professional's assessment of this risk is required prior to use. This ensures safe use consistent with the drug's established risk profile.
Q: Is Diclac considered a stronger pain reliever compared to common over-the-counter options?
Clinical studies have investigated diclofenac's effectiveness compared to common over-the-counter pain relievers like ibuprofen. Official information indicates that, for acute pain relief, certain diclofenac formulations provide relief that is comparable to or, in some cases, greater than standard OTC NSAIDs. Information regarding suitable pain relief is determined by healthcare professionals, based on a patient's condition.
Q: What are the main differences between Diclac and ibuprofen?
Both medicines are classified as non-steroidal anti-inflammatory drugs (NSAIDs). Diclofenac is recognized in medical literature for having a particularly strong anti-inflammatory effect. While both carry similar potential risks, official warnings emphasize diclofenac's cardiovascular risk more prominently than many other NSAIDs.
Q: How does the action of Diclac compare to Naproxen?
Both Diclac (diclofenac) and naproxen are NSAIDs that work by reducing pain and inflammation. Regulatory warnings state that diclofenac is associated with a greater risk of cardiovascular events compared to naproxen. Official pharmacological reviews suggest diclofenac may have a greater impact on the COX-2 enzyme pathway than naproxen.
Q: Does Diclac treat inflammation differently than Acetaminophen (Tylenol)?
Yes, Diclac is an NSAID, which works by blocking the body's processes that cause pain, fever, and inflammation. Acetaminophen (Tylenol) is not an NSAID; it relieves pain and fever primarily by acting on the central nervous system. Acetaminophen does not significantly treat inflammation in the body tissues.
Q: How does the topical Diclac gel differ from the oral tablets in terms of effects on the body?
The regulatory information indicates that the gel's absorption into the bloodstream is significantly lower than that of the oral tablet. This difference means the gel concentrates the medicine locally in the inflamed tissue. This localized effect helps minimize the risk of systemic, or body-wide, side effects.
Q: Can Diclac cause ringing in the ears (tinnitus)?
Yes, official regulatory documents list tinnitus, which is described as ringing or buzzing in the ears, as a recognized potential side effect. This is included in the adverse reaction sections of the official product information for diclofenac.
Q: Does Diclac carry a boxed warning about potential cardiovascular risks, such as heart attack or stroke?
Yes. The FDA requires diclofenac to carry a Boxed Warning, which is the agency's most serious warning. This warning highlights the increased risk of potentially fatal cardiovascular events (such as heart attack or stroke) and serious gastrointestinal events (like bleeding and ulcers).
Q: What are the specific signs that may indicate a serious side effect from Diclac is occurring?
The regulatory documents describe several serious adverse events. Symptoms associated with these events include: passing dark or bloody stools (indicating GI bleeding), severe, unexplained chest pain, or a sudden onset of yellowing of the skin or eyes (jaundice). Other symptoms include sudden weakness, slurred speech, or unexplained swelling.
Q: What is the official information regarding Diclac's potential effect on blood pressure?
Official warnings state that using Diclac can be associated with the development of new hypertension or the worsening of high blood pressure already present. Regulatory guidance indicates that blood pressure monitoring is necessary throughout the course of treatment.
Q: What is the difference between the forms Diclofenac Sodium and Diclofenac Potassium?
The two most common forms, diclofenac sodium and diclofenac potassium, differ in how quickly the medicine is released. Diclofenac Potassium is typically used in immediate-release formulations that offer a quicker onset of action. Diclofenac Sodium is often used in delayed- or extended-release forms intended for managing chronic conditions.
Q: What is the purpose of the enteric coating found on some Diclac tablets?
The enteric coating is a safety feature on certain tablets. Official prescribing information states the coating prevents the tablet from dissolving in the stomach's strong acid environment. The coating allows the medicine to pass into the intestine, which protects the stomach lining from potential irritation and damage.
Q: What conditions, besides arthritis, are officially listed as indications for Diclac use?
Official regulatory indications go beyond general arthritis and joint discomfort. Depending on the specific formulation, diclofenac is officially approved to treat conditions such as rheumatoid arthritis, ankylosing spondylitis, gouty arthritis, primary dysmenorrhea (painful periods), and certain types of acute migraine headaches.
Q: Is it permissible to take Diclac if I have a history of asthma or nasal polyps?
Official regulatory labeling contraindicates the use of Diclac in patients who have previously experienced asthma attacks, angioedema, or acute rhinitis after taking aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs). This is due to the potential for a severe allergic-type reaction.
Q: Does using Diclac have any known effect on drug screening tests?
According to regulatory substance classifications, Diclac is a non-steroidal anti-inflammatory drug (NSAID). It is not classified as a controlled substance like a narcotic or opioid. Therefore, it is not typically detected in standard drug screening tests.
Q: How quickly can a person usually expect Diclac to begin providing pain relief?
Official pharmacokinetic data indicates that relief can begin relatively quickly, especially with immediate-release formulations. For the immediate-release potassium salt, peak blood levels are typically reached within about one hour in individuals who are fasting. The exact time it takes to feel relief depends on the specific formulation being used.
